Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 3, 1996, Pages 320-326

  Martel, F ^b   Vetter, T ^a   Russ, H ^c   Grundemann D ^a   Azevedo, I ^b   Koepsell, H ^d   Schomig E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

1 Methyl 4 phenylpyridinium; OCT1; Rat liver; Transport of organic cations; Type I hepatic transport of cationic drugs

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,1' DIETHYL 2,2' CYANINE; 1,1' DIISOPROPYL 2,4' CYANINE; CARRIER PROTEIN; CATION; CLONIDINE; CORTICOSTERONE; CYANINE 863; O METHYLISOPRENALINE; QUINIDINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; ION TRANSPORT; KIDNEY CELL; LIVER CELL; MOLECULAR CLONING; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELLS, CULTURED; HUMANS; LIVER; NEUROTRANSMITTER AGENTS; PYRIDINIUM COMPOUNDS; QUINOLINIUM COMPOUNDS; RATS;

EID: 0029841766     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cheng Y-C, Prusoff W (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
2. Di Monte D, Ekstrom G, Shinka T, Smith M, Trevor A, Castagnoli Jr N (1987) Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Chem Biol Interact 62:105-116
3. Eaton D, Klaassen C (1978) Carrier-mediated transport of the organic cation procaine amide ethobromide by isolated rat liver parenchymal cells. J Pharmacol Exp Ther 206:595-606
4. Graham F, Smiley J, Russell W, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-72
5. Gründeniann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549-552
6. Klaassen C, Watkins III J (1984) Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1-67
7. Lowry O, Rosenbrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
8. MacGregor G, Caskey C (1989) Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucl Acids Res 17:2365
9. 3H-noradrenaline by isolated hepatocytes and liver slices of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 348:350-357
10. Meijer D (1989) Transport and metabolism in the hepatobiliary system. In: Schulz S, Forte J, Rauner BB (eds) The gastrointestinal system, vol 3. University Press, Oxford, pp 717-758
11. Meijer D, Mol W, Müller M, Kurz G (1990) Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokinet Biopharm 18:35-70
12. Mol W. Müller M, Kurz G, Meijer D (1992) Investigations on the hepatic uptake systems for organic cations with a photoaffinity probe of procainamide ethobromide. Biochem Pharmacol 43: 2217-2226
13. Moseley R, Jarose M, Permoad P (1992) Organic cation transport by rat liver plasma membrane vesicles: studies with tetraethylammonium. Am J Physiol 263:G775-G785
14. Moseley R, Smit H, van Solkema B, Wang W, Meijer D (1994) Mechanisms for the hepatic uptake and biliary excretion of cationic drugs. Hepatology 20:261A
15. Moseley R, Smit H, van Solkema B, Wang W, Meijer D (1996) Mechanisms for the hepatic uptake and biliary excretion of tributylmethylammonium: studies with rat liver plasma membrane vesicles. J Pharmacol Exp Ther 276:561-567
16. 2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system. J Pharmacol Exp Ther 269:1220-1227
17. Oude Elferink R, Meijer D, Kuipers F, Jansen P, Groen A, Groothuis G (1995) Hepatohiliary secretion of organic compounds; molecular mechanism of membrane transport. Biochim Biophys Acta 1241:215-268
18. Rennick B (1981) Renal tubule transport of organic cations. Am J Physiol 240:F83-F89
19. Rennick B, Kandel A, Peters I, (1956) Inhibition of the renal tubular excretion of tetraethylammonium and N′-methylnicotinamide by basic cyanine dyes. J Pharmacol Exp Ther 118:204-219
20. Russ H, Engel W, Schömig E (1993a) Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline transport inhibitors: synthesis, detection and biological activity. J Med Chem 36:4208-4214
21. Russ H, Sonna J, Keppler K, Baunach S, Schömig E (1993b) Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg's Arch Pharmacol 348:458-465
22. Russ H, Staudt K, Gliese M, Schömig E (1994) The extraneuronal monoamine transporter exists in the central nervous system. Can J Physiol Pharmacol 72:324
23. Russ H, Staudt K, Martel F, Gliese M, Schömig E (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256-1264
24. Schömig E, Babin-Ebell J, Russ H (1993) 1,1′-Diethyl-2,2′-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn-Schmiedeberg's Arch Pharmacol 347:379-383
25. Schömig E, Schönfeld C-L (1990) Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn-Schmiedeberg's Arch Pharmacol 341:404-410
26. Segel I (1975) Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley, New York London Sydney Toronto
27. Singh Y, Swanson E, Sokoloski E, Kutty R, Krishna G (1988) MPTP and MPTP analogs induce cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites. Toxicol Appl Pharmacol 96:347-359
28. 2) exists in the human central nervous system (CNS). Naunyn-Schmiedeberg's Arch Pharmacol 347:R118
29. 2) in human glioma cells. Naunyn-Schmiedeberg's Arch Pharmacol 353:328-333
30. Takano M, Inui K-I, Okano T, Saito H, Hori R (1984) Carrier-mediated transport systems of tetraethylammonium in ral renal brush-border and basolateral membrane vesicles. Biochim Biophys Acta 773:113-124
31. Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N (eds) Catecholamines I, vol 90. Springer, Berlin Heidelberg New York London Tokyo, pp 279-319
32. Ullrich K, Rumrich G, David C, Fritzsch G (1993) Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. I. Amines, piperidines, piperazines, azepines, pyridines, quinolines, imidazoles, thiazoles, guanidines and hydrazines. Eur J Physiol 425:280-299
33. Wilkinson L (1989) SYSTAT: the system for statistics. SYSTAT Inc., Evanston, Ill, USA
34. Wright S, Wunz T (1987) Transport of tetraethylammonium by rabbit renal brush-border and basolateral membrane vesicles. Am J Physiol 253:F1040-F1050
35. Xie M, Cochran M, Lidofsky S, Scharschmidt B (1992) A 1.8-3 kB mRNA encodes for a hepatic organic cation transport protein. Hepatology 16 [Suppl]:147A